Vanberra Signal

Medimagemetric

Curated by Signal

Quantitative susceptibility mapping tool

Overview

Quantitative susceptibility mapping tool. It supports image acquisition, reconstruction, and 3 D visualization. QSM enables the investigation of tissue magnetic susceptibility using magnetic resonance imaging and is useful for the identification and quantification of specific biomarkers including iron, calcium, gadolinium, and superparamagnetic iron oxide (SPIO) nanoparticles. It can be used for diagnosis study of Intracerebral Hemorrhage, Intracranial calcification, Neurodegenerative Diseases, and for contrast agent quantification.

Key facts

Founded
2011

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Online pharmacy for cannabis wellness and recreational products

    Health TechnologyGrand Junction, United States
  • Provides cloud-based technology for PM and EHR management for oncology clinics

    Health TechnologyCincinnati, United States
  • Provider of medical cannabis card on doctor consultation and recommendation

    Health TechnologyVilla Park, United States

About Medimagemetric

What does Medimagemetric do?

Quantitative susceptibility mapping tool.

Where is Medimagemetric headquartered?

Medimagemetric is headquartered in New York City, United States.

When was Medimagemetric founded?

Medimagemetric was founded in 2011.

Which sector is Medimagemetric in?

Medimagemetric operates in Health Technology.

Who are Medimagemetric's competitors?

Companies similar to Medimagemetric include Fire Supplements, Electronic Registry Systems, and Medical Cannabis Doctors.